Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
BMC Public Health|January 27, 2018
Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UKD Gareth Evans, Adam R Brentnall, Michelle Harvie, et al.Disease Markers|June 23, 2011
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencingNataša Vasiljević, Keqiang Wu, Adam R Brentnall, et al.Breast Cancer Research and Treatment|April 4, 2019
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variantsD Gareth R Evans, Elaine F Harkness, Adam R Brentnall, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 15, 2022
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panelD Gareth R Evans, Elke M van Veen, Elaine F Harkness, et al.Breast Cancer Research : BCR|February 7, 2018
A comparison of five methods of measuring mammographic density: a case-control studySusan M Astley, Elaine F Harkness, Jamie C Sergeant, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.Cancers|February 25, 2023
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UKSamuel Oxley, Ashwin Kalra, Michail Sideris, et al.Breast Cancer Research : BCR|December 3, 2015
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohortAdam R Brentnall, Elaine F Harkness, Susan M Astley, et al.BMC Cancer|June 20, 2020
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)David P French, Susan Astley, Adam R Brentnall, et al.Pageof 8